EZH2 also plays a pivotal role in modulating immune cell differentiation (Karantanos et al., 2016), and targeted EZH2 disruption in regulatory T cells has been shown to enhance anti-tumor immune responses in mouse tumor models (Wang et al., 2018, Goswami et al., 2018). The gene discussed is EZH2; the disease is neoplasm.